Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.29%)
As of: Sep 9, 2026 · 3:07 PM EDT

Prokidney (PROK) Selling, General & Administrative (2021 - 2026)

Analysis

Prokidney (PROK) Selling, General & Administrative (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Krystal Biotech 10.26 Bn 9.41 Bn 112.79 Mn 39.85 Mn
2 CRISPR Therapeutics AG 5.19 Bn 5.19 Bn - 17.55 Mn
3 Iovance Biotherapeutics 3.76 Bn 3.46 Bn 55.72 Mn 39.27 Mn
4 Legend Biotech 3.67 Bn 2.71 Bn 251.50 Mn -33.00 Mn
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn 17.37 Mn
6 Beam Therapeutics 2.67 Bn 2.67 Bn - 31.95 Mn
7 Precigen 2.43 Bn 2.43 Bn 52.17 Mn 22.25 Mn
8 Sarepta Therapeutics 2.33 Bn 1.54 Bn 251.87 Mn 107.60 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 48.48 Mn
10 Prokidney 342.34 Mn 342.34 Mn - 12.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.43 Mn
Mar 31, 2026 11.32 Mn
Dec 31, 2025 11.44 Mn
Sep 30, 2025 11.94 Mn
Jun 30, 2025 14.05 Mn
Mar 31, 2025 14.36 Mn
Dec 31, 2024 11.87 Mn
Sep 30, 2024 17.72 Mn
Jun 30, 2024 13.65 Mn
Mar 31, 2024 12.84 Mn
Dec 31, 2023 1.68 Mn
Sep 30, 2023 14.42 Mn
Jun 30, 2023 13.46 Mn
Mar 31, 2023 15.26 Mn
Dec 31, 2022 9.35 Mn
Sep 30, 2022 14.44 Mn
Jun 30, 2022 9.18 Mn
Mar 31, 2022 37.97 Mn
Dec 31, 2021 3.02 Mn
Sep 30, 2021 2.34 Mn